Silver Spike Investment (NASDAQ:SSIC – Get Rating) had its price objective raised by Stifel Nicolaus from $8.00 to $8.80 in a research report released on Monday morning, The Fly reports.
Silver Spike Investment Trading Up 0.1 %
NASDAQ:SSIC opened at $8.59 on Monday. Silver Spike Investment has a 1-year low of $7.70 and a 1-year high of $12.94. The company’s fifty day moving average price is $8.60 and its 200-day moving average price is $9.40.
Institutional Trading of Silver Spike Investment
A hedge fund recently bought a new stake in Silver Spike Investment stock. Penserra Capital Management LLC purchased a new stake in shares of Silver Spike Investment Corp. (NASDAQ:SSIC – Get Rating) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 109,935 shares of the company’s stock, valued at approximately $1,462,000. Penserra Capital Management LLC owned 1.81% of Silver Spike Investment as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 5.81% of the company’s stock.
Silver Spike Investment Company Profile
Silver Spike Investment Corp., is a a business development company. It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies. It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies.
Further Reading
- Get a free copy of the StockNews.com research report on Silver Spike Investment (SSIC)
- FREYR Battery Is An Interesting Play On EVs: At Rock Bottom
- Analysts Upgrade GXO Logistics, Its First Quarter Says It All
- The Bottom Is In For AppLovin; Reversal Is NextÂ
- Exact Sciences Serves Investors Exactly What They Wished For
- Shockwave Medical, Fast Grower, In Boston Scientific’s Sights?
Receive News & Ratings for Silver Spike Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silver Spike Investment and related companies with MarketBeat.com's FREE daily email newsletter.